Seasoned biotechnology CEO brings 25 years of strategic, operational and commercial expertiseFOSTER CITY, Calif., Feb. 20, ...

BMS’ Breyanzi and Amgen’s Blincyto will now be available to patients in England with certain types of blood cancer.

BioAsia 2025 to host Global Healthcare Leaders to drive transformative innovation: Our Bureau, Mumbai Saturday, February 22, 2025, 08:00 Hrs [IST] Bio Asia, Asia's premier life sc ...

Telangana Chief Minister A. Revanth Reddy, Union Commerce and Industry Minister Piyush Goyal, G20 Sherpa Amitabh Kant and ...

Teva and Alvotech are introducing Selarsdi at an 85% discount off the reference product Stelara. Selarsdi is available as a subcutaneous injection and for intravenous infusion.

South Korea-based Celltrion today announced that the European Commission (EC) has granted marketing authorization for three ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two ...

Healthcare inflation outpaces CPI due to provider shortages. Find out why income investing ensures steady returns despite ...

South Korean biosimilars company Samsung Bioepis has announced that the US Food and Drug Administration (FDA) and European ...

Achieved $61.5 million and $172.0 million in fourth quarter and full year 2024 OGSIVEO® (nirogacestat) U.S. net product revenues, respectively ...